Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01276704 · ClinicalTrials.gov registry record · Phase 2
Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer
A Phase 2 study, sponsored by Carol Fabian, MD.
- Terminated
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
NCT01276704: Clinical Trial Phase 2 study, sponsored by Carol Fabian, MD.
NCT01276704 is a Phase 2 study that was terminated before completion, run by Carol Fabian, MD. The registered enrollment target is 180 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01276704, a Phase 2 study, was terminated before completion, sponsored by Carol Fabian, MD.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
Study Summary
The investigators will study the effect of 12 months of SDG (Brevail) vs placebo on women at increased risk for development of breast cancer.
Primary Outcome
Change over the course of study in the percent of breast epithelial cells expressing the proliferation marker Ki- 67/MIB-1 in hyperplastic benign breast tissue acquired by random periareolar fine needle aspiration pre-study and post-study.
Interventions
- DRUG Placebo
- DRUG secoisolariciresinol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2011-01 |
| Est. Completion | 2017-07 |
| Phase | Phase 2 |
Why NCT01276704 stopped before completion
NCT01276704 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01276704 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01276704 about?
NCT01276704 is a clinical study titled "Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer". The investigators will study the effect of 12 months of SDG (Brevail) vs placebo on women at increased risk for development of breast cancer.
What is the current status of trial NCT01276704?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2011-01. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01276704?
The interventions under investigation include: Placebo (DRUG), secoisolariciresinol (DRUG).
Who is sponsoring clinical trial NCT01276704?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01276704's enrollment target sits among peer trials
180 365th of 2000 higher than 1,610 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia